Do birth outcomes mediate the association between drug use in pregnancy and neonatal metabolic bone disease? A prospective cohort study of 10,801 Chinese women
Comprehensive medication use during pregnancy was associated with an increased risk of neonatal MBD, largely mediated by LBW. Early antepartum monitoring and prevention targeting adverse birth outcomes are necessary to mitigate the risk of MBD.
Authors
- Wenchong Du (ORCID: https://orcid.org/0000-0002-5115-7214)
- H. Li
- Hao Ying (ORCID: https://orcid.org/0000-0001-7001-5206)
- Federico Canavese (ORCID: https://orcid.org/0000-0002-6114-5372)
- Jing Li (ORCID: https://orcid.org/0009-0003-2507-1606)
- Chunlin Li (ORCID: https://orcid.org/0000-0002-9284-1901)
- Jing Hua (ORCID: https://orcid.org/0000-0001-7613-0926)
- Honglin Jiang (ORCID: https://orcid.org/0000-0001-8815-0780)
- Jialin Guo (ORCID: https://orcid.org/0000-0001-8056-994X)
- Jian Yang
- Feng Xie
Institutions
- Singapore Institute of Technology (SG)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- Lille’s Cardiology Hospital (FR)
- Shanghai Research Institute of Sports Science (CN)
- Shanghai First Maternity and Infant Hospital (CN)
- Nottingham Trent University (GB)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3389/fpubh.2024.1377070
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality